Skip to search formSkip to main contentSkip to account menu

MGr1-antigen, human

Known as: MGr1-Ag 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Antigens, Neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
MGr1-Ag/37LRP promotes growth and proliferation of gastric cancer in vitro and in vivo
Gastric carcinoma (GC) is an aggressive cancer with a poor prognosis. We previously reported that MGr1-Ag was involved in… 
2013
2013
MGr 1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo
Bone metastasis of small-cell lung cancer (SCLC) usually occurs early in the progression of the disease. However, the molecular… 
2013
2013
MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.
Bone metastasis of small-cell lung cancer (SCLC) usually occurs early in the progression of the disease. However, the molecular… 
2011
2011
Bleomycin treatment of A549 human lung cancer cells results in association of MGr1-Ag and caveolin-1 in lipid rafts.
2007
2007
Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells
Drug resistance is a major obstacle in the development of effective cancer therapy. It was reported that many chemotherapeutic… 
2005
2005
Regulation of Multidrug Resistance by MGr1-Antigen in Gastric Cancer Cells
Previously, a novel protein, MGr1-Ag, was associated with tumor multidrug resistance (MDR), and the role and the underlying… 
2002
2002
Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor
Abstract. We report the isolation and functional characterization of the gene encoding MGr1-Ag, a multidrug-resistance-associated… 
2002
2002
MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells
Abstract.Background: MGr1-antigen (Ag) was previously reported as an upregulated protein in multidrug-resistant (MDR) gastric… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)